Table 6.
Univariate and Multivariate Analysis of COVID-19 Patients with Death
| Indicators | Univariate Analysis OR (95% CI) | P value | Multivariate Analysis OR (95% CI) | P value |
|---|---|---|---|---|
| Sex, male | 1.906 (1.105–3.289) | 0.02 | 0.854 (0.225–3.232) | 0.816 |
| Age, years | 1.098 (1.069–1.128) | <0.001 | 1.126 (1.056–1.2) | <0.001 |
| Diabetes | 2.938 (1.614–5.348) | <0.001 | 2.444 (0.634–9.42) | 0.194 |
| Fever | 9.947 (1.353–73.143) | 0.024 | 15.352 (0.641–367.512) | 0.092 |
| Dyspnea | 4.516 (2.544–8.016) | <0.001 | 3.007 (0.835–10.82) | 0.092 |
| CRP, mg/L | 1.025 (1.019–1.03) | <0.001 | 0.996 (0.983–1.009) | 0.557 |
| WBC count, ×109 /L | 1.602 (1.431–1.794) | <0.001 | 1.373 (1.097–1.72) | 0.006 |
| Lymphocyte count, ×109 /L | 0.024 (0.009–0.063) | <0.001 | 0.321 (0.056–1.827) | 0.2 |
| Eosinophil count, ×109 /L | 0 (0–0) | <0.001 | 0 (0–0.004) | 0.016 |
| Albumin, g/L | 34.777 (8.397–144.036) | <0.001 | 4.012 (0.317–50.806) | 0.283 |
| Globulin, g/L | 1.175 (1.109–1.244) | <0.001 | 0.944 (0.817–1.089) | 0.427 |
| AST, U/L | 1.024 (1.015–1.034) | <0.001 | 0.98 (0.952–1.009) | 0.171 |
| Creatinine, μmol/L | 1.007 (1.002–1.013) | 0.01 | 1.006 (0.997–1.016) | 0.207 |
| TBil, μmol/L | 1.146 (1.095–1.199) | <0.001 | 1.028 (0.9101.161) | 0.657 |
| ALP, U/L | 1.009 (1.003–1.015) | 0.004 | 1 (0.98–1.02) | 0.997 |
| LDH, U/L | 1.013 (1.01–1.015) | <0.001 | 1.011 (1.005–1.017) | 0.001 |
| CK, μmol/L | 1.003 (1.002–1.005) | <0.001 | 1 (0.996–1.003) | 0.953 |
| APTT, seconds | 1.054 (1.018–1.091) | 0.003 | 1.14 (1.044–1.244) | 0.003 |
| D-dimer, μg/mL | 1.2 (1.143–1.26) | <0.001 | 1.057 (0.978–1.142) | 0.161 |
Abbreviations: COVID-19, coronavirus disease 2019; OR, odds ratio; CI, confidence interval; CRP, C-reactive protein; WBC, white blood cell; AST, aspartate aminotransferase; TBil, total bilirubin; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; CK, Creatine kinase; APTT, activated partial thromboplastin time.